Brokerages Set Simulations Plus, Inc. (NASDAQ:SLP) Target Price at $50.00

Simulations Plus, Inc. (NASDAQ:SLP - Get Free Report) has been assigned a consensus rating of "Buy" from the seven analysts that are presently covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation, five have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 month price objective among brokerages that have covered the stock in the last year is $50.00.

A number of equities analysts have issued reports on the stock. Wall Street Zen raised shares of Simulations Plus from a "sell" rating to a "hold" rating in a report on Monday, April 28th. KeyCorp lifted their price target on Simulations Plus from $32.00 to $40.00 and gave the company an "overweight" rating in a report on Wednesday, April 16th. Finally, William Blair reaffirmed an "outperform" rating on shares of Simulations Plus in a report on Tuesday, June 3rd.

Insider Buying and Selling

In other Simulations Plus news, Director Walter S. Woltosz sold 20,000 shares of Simulations Plus stock in a transaction that occurred on Thursday, May 1st. The shares were sold at an average price of $33.51, for a total value of $670,200.00. Following the transaction, the director now owns 3,344,157 shares in the company, valued at approximately $112,062,701.07. The trade was a 0.59% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 19.40% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the business. Jones Financial Companies Lllp grew its position in Simulations Plus by 53.6% in the fourth quarter. Jones Financial Companies Lllp now owns 1,223 shares of the technology company's stock worth $34,000 after buying an additional 427 shares during the last quarter. Fifth Third Bancorp grew its position in Simulations Plus by 33.8% in the first quarter. Fifth Third Bancorp now owns 1,485 shares of the technology company's stock worth $36,000 after buying an additional 375 shares during the last quarter. Johnson Financial Group Inc. purchased a new position in Simulations Plus during the 4th quarter worth approximately $39,000. Tower Research Capital LLC TRC grew its position in Simulations Plus by 42.2% during the 4th quarter. Tower Research Capital LLC TRC now owns 2,575 shares of the technology company's stock worth $72,000 after purchasing an additional 764 shares in the last quarter. Finally, AlphaQuest LLC grew its position in Simulations Plus by 502.9% during the 4th quarter. AlphaQuest LLC now owns 2,689 shares of the technology company's stock worth $75,000 after purchasing an additional 2,243 shares in the last quarter. Institutional investors and hedge funds own 78.08% of the company's stock.

Simulations Plus Stock Performance

Shares of SLP stock traded down $0.12 during trading hours on Friday, hitting $27.43. 217,267 shares of the company were exchanged, compared to its average volume of 225,999. The business's 50-day simple moving average is $30.70 and its two-hundred day simple moving average is $30.39. Simulations Plus has a one year low of $23.01 and a one year high of $50.11. The stock has a market capitalization of $551.64 million, a price-to-earnings ratio of 68.58 and a beta of 0.97.

Simulations Plus (NASDAQ:SLP - Get Free Report) last issued its earnings results on Thursday, April 3rd. The technology company reported $0.31 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.25 by $0.06. Simulations Plus had a net margin of 10.97% and a return on equity of 6.84%. The firm had revenue of $22.43 million for the quarter, compared to analysts' expectations of $21.93 million. During the same quarter last year, the company posted $0.20 earnings per share. Simulations Plus's revenue was up 22.5% on a year-over-year basis. As a group, analysts anticipate that Simulations Plus will post 1.09 EPS for the current fiscal year.

About Simulations Plus

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.